Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1993 1
1994 1
1995 5
1996 2
1997 2
1998 7
1999 6
2000 5
2001 2
2002 4
2003 7
2004 12
2005 11
2006 15
2007 22
2008 14
2009 15
2010 15
2011 18
2012 20
2013 17
2014 11
2015 5
2016 10
2017 9
2018 3
2019 2
2020 2
2021 2
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Diabetes Mellitus and the Heart.
Schütt K, Forst T, Birkenfeld AL, Zirlik A, Müller-Wieland D, Marx N. Schütt K, et al. Among authors: forst t. Exp Clin Endocrinol Diabetes. 2022 Sep;130(S 01):S123-S126. doi: 10.1055/a-1624-3593. Epub 2022 Mar 31. Exp Clin Endocrinol Diabetes. 2022. PMID: 35359012 No abstract available.
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus.
Giorgino F, Battelino T, Bergenstal RM, Forst T, Green JB, Mathieu C, Rodbard HW, Schnell O, Wilmot EG. Giorgino F, et al. Among authors: forst t. J Diabetes Sci Technol. 2023 Nov 8:19322968231204584. doi: 10.1177/19322968231204584. Online ahead of print. J Diabetes Sci Technol. 2023. PMID: 37937585 Free article. Review.
Diabetes Mellitus and the Heart.
Schütt K, Forst T, Birkenfeld AL, Zirlik A, Müller-Wieland D, Marx N. Schütt K, et al. Among authors: forst t. Exp Clin Endocrinol Diabetes. 2024 Feb;132(2):64-67. doi: 10.1055/a-2166-6885. Epub 2024 Jan 23. Exp Clin Endocrinol Diabetes. 2024. PMID: 38262445 No abstract available.
Intensification with prandial insulin.
Pfützner A, Forst T. Pfützner A, et al. Among authors: forst t. Int J Clin Pract Suppl. 2009 Oct;(164):11-4. doi: 10.1111/j.1742-1241.2009.02174.x. Int J Clin Pract Suppl. 2009. PMID: 19751454 Review.
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Schnell O, Cos X, Cosentino F, Forst T, Giorgino F, Heersprink HJL, Kosiborod M, Wanner C, Standl E. Schnell O, et al. Among authors: forst t. Cardiovasc Diabetol. 2021 Mar 31;20(1):75. doi: 10.1186/s12933-021-01254-1. Cardiovasc Diabetol. 2021. PMID: 33789663 Free PMC article.
239 results